BSE filing, NSE: STEELXIND. Summary written from the filing by ALFA Finder's alert engine.
Steel Exchange India Ltd: key numbers
- Share price
- ₹9.93
- Market cap
- ₹1,267 Cr
- Revenue (annual)
- ₹1,059 Cr
- Net profit (annual)
- ₹26.99 Cr
- P/E (TTM)
- 39.9×Sector 16.7×
- Promoter holding
- 49.67%+0.00% QoQ
- FII holding
- 0.52%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Steel Exchange India Ltd
All →Steel Exchange India Board Meeting Date
Steel Exchange India scheduled a board meeting for 04 Nov 2026 to consider unaudited Q2/H1 results. No financial figures or material decisions are reported in this advance intimation.
Steel Exchange India Other Announcement
Steel Exchange India Ltd filed its quarterly shareholding pattern. It noted the transmission of 43,31,500 shares due to a promoter's death.
Steel Exchange India Business Update
Steel Exchange reported record Re-Bar production, a two-notch credit upgrade, and ₹102 Crore debt reduction in H1 FY27, alongside an NMDC supply MoU.
- quarterly Re-Bar production
- 69617.424 MT
Steel Exchange India Results Update
SEIL posted provisional Q2 FY27 revenue of ~₹340 Crore, up 45% YoY, on record Re-Bar output of 69,465 MT. PLI diversification and operational gains mark its turnaround.
Steel Exchange India Debt & Borrowing: ₹4.29 Cr
Steel Exchange India Limited made a scheduled partial redemption and interest payment totaling ₹4.29 Crore on its Secured Non-Convertible Debentures, complying with Regulation 57(1) of SEBI (LODR).
- Value
- ₹4.29 Cr
Steel Exchange India Business Update
Steel Exchange India Limited achieved record production of 25,095.035 MT of re-bars in September 2026. Quarterly production also reached a new high of 69,617.424 MT.
- quarterly production
- 69617.424 MT
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.